ENA 100 Pill: yellow, capsule/oblong, 15mm
Generic Name: enasidenib
The pill with imprint ENA 100 (Yellow, Capsule/Oblong, 15mm) has been identified as Idhifa 100 mg and is used for Acute Myeloid Leukemia. It belongs to the drug class miscellaneous antineoplastics and is not a controlled substance.
Images for ENA 100
Idhifa
- Generic Name
- enasidenib
- Imprint
- ENA 100
- Strength
- 100 mg
- Color
- Yellow
- Size
- 15.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Celgene Corporation
- National Drug Code (NDC)
- 59572-0710
- Inactive Ingredients
-
microcrystalline cellulose,
sodium starch glycolate type A potato,
sodium lauryl sulfate,
hypromellose acetate succinate,
silicon dioxide,
magnesium stearate,
polyvinyl alcohol,
titanium dioxide,
polyethylene glycol,
magnesium silicate,
ferric oxide yellow
Note: Inactive ingredients may vary.
See also:
More about Idhifa (enasidenib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.